Results 21 to 30 of about 4,990 (168)

Spectrum of hemolytic transfusion reactions from tertiary cancer center over a 1-year period

open access: yesGlobal Journal of Transfusion Medicine, 2023
Background and Objectives: Acute hemolytic transfusion reactions (HTRs) one of the serious adverse events manifesting within 24 h of blood transfusion. To review the adverse transfusion reactions in our cancer center over a 1-year period, especially HTR ...
Valathuparambil Jalaludheen Fathima   +2 more
doaj   +1 more source

FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization

open access: yesFrontiers in Immunology, 2022
Passive immunization with anti-D can prevent maternal alloimmunization to RhD thereby preventing hemolytic disease of the fetus and newborn. Unexpectedly, anti-D fails in some cases and some monoclonal anti-D preparations paradoxically enhances ...
Annie Qiu   +10 more
doaj   +1 more source

Indirect T Cell Allorecognition and Alloantibody-Mediated Rejection of MHC Class I-Disparate Heart Grafts [PDF]

open access: yes, 2001
The T cell allorecognition pathways responsible for the rejection of MHC class I disparate allografts remain poorly defined. The respective contributions of the 'direct' recognition of the allogeneic class I molecule by recipient CD8 T cells, and the ...
Pettigrew, Gavin J
core   +6 more sources

Alloantibody assays and outcome of platelet transfusions [PDF]

open access: yes, 2004
In this thesis we deal with two aspects of alloantibody assays: (i) test characteristics and (ii) performance of tests in different patient populations.
Levin, Mark-David   +1 more
core   +1 more source

Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania

open access: yesAfrican Journal of Laboratory Medicine, 2020
Background: Erythrocyte alloimmunisation can lead to complications such as delayed haemolytic transfusion reaction. Objective: This study investigated the prevalence of and risk factors for red blood cell alloimmunisation among multiply transfused ...
Erius Tebuka   +2 more
doaj   +1 more source

Red Blood Cell Alloantibody Development Among Multi-transfused Patients In A Single Tertiary Centre [PDF]

open access: yes, 2023
OBJECTIVES This research aimed to determine the prevalence, frequency, and specificity of RBC alloantibody and to evaluate the factors associated with its development among multi transfused patients in a single tertiary hospital.
Ismail, Hannah
core  

Transfusion support in a severe autoimmune hemolytic anemia patient associated with systemic lupus erythematosus and antiphospholipid syndrome

open access: yesIraqi Journal of Hematology, 2021
A positive direct antiglobulin test is a criterion for the diagnosis of systemic lupus erythematosus (SLE). In general, severe hemolysis is absent in SLE.
Debasish Mishra   +3 more
doaj   +1 more source

Red Blood Cell Alloimmunization and Its Associated Factors among Chronic Liver Disease Patients in a Teaching Hospital in Northeastern Malaysia

open access: yesDiagnostics, 2023
Red blood cell (RBC) alloimmunization is an important complication of blood transfusion. Variations in the frequency of alloimmunization have been noted among different patient populations. We aimed to determine the prevalence of RBC alloimmunization and
Siti Zaleha S. Abdullah   +4 more
doaj   +1 more source

Critical Role of NKT Cells in Posttransplant Alloantibody Production

open access: yes, 2014
We previously reported that posttransplant alloantibody production in CD8-deficient hosts is IL-4+ CD4+ T cell-dependent and IgG1 isotype-dominant. The current studies investigated the hypothesis that IL-4-producing natural killer T cells (NKT cells ...
J. M. Zimmerer   +15 more
core   +1 more source

Wild Felids Blood Group System

open access: yesAnimals, 2021
Wild felids and domestic cats share the AB blood group. However, there have been few studies regarding the characterization and prevalence of the different blood types in wild animals.
Ana Silvestre-Ferreira, Josep Pastor
doaj   +1 more source

Home - About - Disclaimer - Privacy